NE-3107 Alzheimer's, Parkinson's data boost Biovie

BioVie (BIVI): Treating Alzheimer's, Parkinson's, Reversing The Biological Clock

NE-3107 Alzheimer's, Parkinson's data boost Biovie

ON-104 demonstrates efficacy in preclinical models of chronic inflammatory disease

Triolex - Drug Targets, Indications, Patents - Synapse

Analysis and data insight

Lucy Therapeutics validates new mitochondrial-based therapeutic approach for Parkinson's disease

Anette Breindl

BioVie (BIVI): Treating Alzheimer's, Parkinson's, Reversing The Biological Clock

BioVie (BIVI): Treating Alzheimer's, Parkinson's, Reversing The Biological Clock

Neurology/psychiatric

Grant supports Vesper Bio's development of sortilin inhibitors in Parkinson's disease

dementia BioWorld

BioVie aims to treat Parkinson's and Alzheimer's by focusing on inflammation